Cancer Research U.K. has launched a large, multicenter trial to test a new device for detecting Barrett's esophagus, a condition that puts sufferers at increased risk of developing cancer of the ...
UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced today that its ...
NEW YORK, April 24, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (LUCD) (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
Researchers sought to determine the effect of long-term opioid exposure on esophageal motility, using a large cohort. Dysphagia occurs in nearly 2 of 3 individuals receiving treatment with opioids and ...
UNIONDALE, NY, June 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the ...
ProPhase Labs announces BE-Smart's validation for esophageal disease diagnostics, achieving over 95% success in detecting critical biomarkers. ProPhase Labs Inc. announced the successful validation of ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a randomized ...
Results indicate potential of a minimally invasive screening tool to detect most common form of Esophageal Cancer, a highly treatable cancer if caught early MADISON, Wis.--(BUSINESS WIRE)-- Exact ...
In healthy swallowing, liquid quickly passes from the mouth to the stomach. In individuals with esophageal motility disorders, this process is disrupted. Fukuoka, Japan—For most people, swallowing is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results